Tech Stocks Tumble on Earnings and Guidance Misses, Market Rotation Continues

1 hour ago 2 sources neutral

Key takeaways:

  • Crypto's resilience amid tech sell-offs hints at growing decorrelation from equities.
  • Profit-taking in overextended memory stocks mirrors risks for surged altcoins like BONK.
  • Watch for prolonged equity weakness potentially pressuring speculative crypto positions later.

Investors rotated out of technology stocks on Thursday, triggering sharp declines in several major names even as blue-chip equities held firm. The Dow Jones Industrial Average was on track for its fourth consecutive closing high, while ad-tech and memory stocks led the sell-off.

AppLovin plunged 16% after missing second-quarter revenue and EBITDA expectations. The company's third-quarter revenue guidance of $2.05 billion to $2.08 billion was roughly in line with estimates, but failed to satisfy investors after the stock's strong prior run.

SanDisk dropped around 9% despite reporting fiscal fourth-quarter revenue of $8.97 billion—a 372% year-over-year surge that beat analyst estimates. The core issue was its first-quarter revenue forecast, whose midpoint fell below Wall Street expectations. CEO David Goeckeler emphasized the company's goal to reduce boom-and-bust cycles through deeper customer relationships. The board also authorized an additional $14 billion share repurchase, bringing total buyback capacity to $15.5 billion. Data center revenue more than doubled sequentially to $2.98 billion, but moderating NAND pricing and lower gross margin guidance weighed on sentiment.

Western Digital tumbled 14% despite beating earnings estimates and raising first-quarter guidance. The stock had already surged 176% year-to-date, and profit-taking set in. Other memory-related names followed: Micron slid 3.4% and Seagate declined 3.9%.

On the positive side, SoundHound AI surged 24% after posting second-quarter revenue of $61.9 million, up 45% year over year, and raising its full-year revenue guidance to $230–260 million. Moderna rose 3.5% following FDA approval of its mFLUSIVA influenza vaccine.

The broader market move reflected a rotation from tech into traditional blue chips. While this stock-market reshuffling captures headlines, it had no direct impact on cryptocurrency markets, which remained unaffected by the day's equity volatility.

Disclaimer

The content on this website is provided for information purposes only and does not constitute investment advice, an offer, or professional consultation. Crypto assets are high-risk and volatile — you may lose all funds. Some materials may include summaries and links to third-party sources; we are not responsible for their content or accuracy. Any decisions you make are at your own risk. Coinalertnews recommends independently verifying information and consulting with a professional before making any financial decisions based on this content.